Emerging Biopharma

abstract black agate background with golden veins fake painted artificial stone marble texture
Biotech

Versant unveils new autoimmune biotech with $100M fundraise

Granite has raised combined series A and B funds of $100 million, with support from Versant Ventures, Novartis, Forbion and Sanofi.
Gabrielle Masson Apr 24, 2025 8:00am
Glowing puzzle piece fitting into puzzle

Boehringer slots synthetic lethal program into oncology pipeline

Apr 23, 2025 7:45am
IPO initial public offering

BioNTech backing powers DualityBio toward $200M Hong Kong IPO

Apr 7, 2025 8:21am
boat cutting through water

Harbour launches obesity biotech on mission to preserve muscle

Mar 12, 2025 8:15am
Robotic arm in a lab

Flagship-backed AI firm aims for 'scientific superintelligence'

Mar 10, 2025 1:47pm
bird birds flying humingbirds

Frazier arms Callio with $187M series A to fly Hummingbird's ADC

Mar 3, 2025 9:00am
More News

VC firm launches biotech aiming to counter antibiotic resistance

Feb 24, 2025 7:15am

Radiance joins ROR1 race, paying $15M for ADC to challenge Merck

Feb 19, 2025 7:32am

Newleos unveils with $93M and 4 ex-Roche programs

Feb 13, 2025 12:00am

Versant launches another obesity biotech with $65M series A

Jan 28, 2025 8:35am